Skip to main content

Advertisement

Log in

Biologic and clinical correlations among ploidy, cell kinetics, and the tumor-associated glycoprotein-72 tissue expression in colorectal cancer

Preliminary findings

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: The aim of this study was to evaluate the possibility of identifying biologically aggressive subgroups of patients, combining several biologic parameters such as the tumor and normal mucosa values from the ploidy, the S-phase cell percentage, and tumor-associated glycoprotein-72 (TAG-72) expression. METHODS: One hundred five colorectal cancer patients were studied to analyze the possible prognostic role of ploidy and cell kinetics in multiple fresh specimens from the tumor and normal mucosa. Since the presence of TAG-72 in the colonic mucosa has been correlated to neoplastic transformation, the correlations between these parameters and the quantitative tissue expression of the TAG-72 were analyzed in a subgroup of 53 cases. RESULTS: A significantly lower five-year disease-free survival rate (21.4 percent) was observed in patients with multiploid tumors, when compared with that observed in patients with diploid or single aneuploid tumors (67.5 percent) (P =0.03). The quantitative tissue TAG-72 expression contributed in identifying a particular patient subgroup (20 percent), characterized by S-phase percentage and TAG-72 values from the normal mucosa that were unexpectedly higher than 12.1 percent and 7.5 U/mg of proteins, respectively. In particular, when the 25 Dukes B patients were analyzed, similar results were observed. In fact, 14 (56 percent) cases showed high tumor cell proliferation and, surprisingly, a high tissue TAG-72 content in the normal mucosa was found in 4 (28.6 percent) of these patients. CONCLUSIONS: Other than multiploidy, the biologic aggressiveness of colorectal cancer might be successfully assessed introducing the evaluation of new biologic parameters, such as the TAG-72 content and S-phase percentage values of the normal mucosa, suggesting the possibility of further stratifying this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Williams NN, Gyorfi T, Iliopoulos D,et al. Growthfactor-independence and invasive properties of colorectal carcinoma cells. Int J Cancer 1992;50:274–80.

    PubMed  Google Scholar 

  2. Primus FJ, Newell KD, Blue A, Goldenberg DM. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. Cancer Res 1983;43:686–92.

    PubMed  Google Scholar 

  3. Kokal W, Sheibani K, Terz J, Harada JR. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986;255:3123–7.

    PubMed  Google Scholar 

  4. Jones DJ, More M, Schofield PF. Refining the prognostic significance of DNA ploidy status in colorectal cancer: a prospective flow cytometric study. Int J Cancer 1988;41:206–10.

    PubMed  Google Scholar 

  5. Russo A, Bazan V, Plaja S, Leonardi P, Bazan P. Patterns of DNA ploidy in operable colorectal carcinoma: a prospective study of 100 cases. J Surg Oncol 199;48:4–10.

  6. Armitage NC, Ballantyne KC, Sheffield JP, Clarke P, Evans DF, Hardcastle JD. A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer. Cancer 1991;67:2599–604.

    PubMed  Google Scholar 

  7. Witzig TE, Loprinzi CL, Gonchoroff NJ,et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal carcinomas. Cancer 1991;68:879–88.

    PubMed  Google Scholar 

  8. Dean PA, Vernava AM III. Flow cytometric analysis of DNA content in colorectal carcinoma. Dis Colon Rectum 1992;35:95–102.

    PubMed  Google Scholar 

  9. Frankfurt OS, Arbuck SG, Greco WR,et al. Prognostic significance of DNA aneuploidy in human colorectal cancer. Proc Am Soc Clin Oncol 1984;3:17.

    Google Scholar 

  10. Rognum TO, Thorud E, Lunfd E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer 1987;56:633–41.

    PubMed  Google Scholar 

  11. Cusick EI, Milton JJ, Ewen SW. The resolution of aneuploid DNA stem lines by flow cytometry: limitations imposed by the coefficient of variation and the percentage of aneuploid nuclei. Anal Cell Pathol 1990;2:139–48.

    PubMed  Google Scholar 

  12. Ciaretti W, Danova M, Geido S,et al. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 1991;67:1921–7.

    PubMed  Google Scholar 

  13. Hedley DW. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 1989;10:229–41.

    PubMed  Google Scholar 

  14. Kalliomemi OP. Comparison of fresh and paraffinembedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988;9:164–9.

    PubMed  Google Scholar 

  15. Sikorska H, Shuster J, Gold P. Clinical applications of carcinoembryonic antigen. Cancer Detect Prev 1988;12:321–55.

    PubMed  Google Scholar 

  16. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature 1975;256:494–7.

    Google Scholar 

  17. Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D. Analysis of a human tumorassociated glycoprotein (TAG-72) identified by monoclonal antibody B72.3- Cancer Res 1986;46:850–7.

    PubMed  Google Scholar 

  18. Thor A, Ohuchi N, Szpak CA, Johnston W, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986;46:3118–24.

    PubMed  Google Scholar 

  19. Guadagni F, Roselli M, Amato T,et al. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients. J Surg Oncol 1991;2(Suppl):16–20.

    Google Scholar 

  20. Guadagni F, Roselli M, Amato T,et al. Tumor-associated glycoprotein-72 (TAG-72) serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma: a longitudinal study. Cancer 1991;11:2443–50.

    Google Scholar 

  21. Guadagni F, Roselli M, Ferroni P,et al. Clinical evaluation of the new tumor marker TAG-72. Anticancer Res 1991;11:1389–94.

    PubMed  Google Scholar 

  22. Guadagni F, Roselli M, Cosimelli M,et al. TAG-72 (CA 72.4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer 1993;72:2098–2106.

    PubMed  Google Scholar 

  23. D'Agnano I, Cosimelli M, La Pera A,et al. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma. Anticancer Res 1993;13:699–704.

    PubMed  Google Scholar 

  24. Colcher D, Horan Hand P, Teramoto Y, Wunderlich D, Schlom J. Use of monoclonal antibodies to define the diversity of mammary tumor viral gene products in virions and mammary tumors of the genus Mus. Cancer Res 1981;41:1451–9.

    PubMed  Google Scholar 

  25. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81.

    Google Scholar 

  26. Armitage NC, Ballantyne KC, Evans DF, Clarke P, Sheffield J, Harcastle JD. The influence of tumor cell DNA content on survival in colorectal cancer: a detailed analysis. Br J Cancer 1990;62:852–6.

    PubMed  Google Scholar 

  27. Harlow SP, Eriksen BL, Poggensee L,et al. Prognostic implications of proliferative activity and DNA aneuploidy in Astler Coller Dukes stage C colonic adenocarcinomas. Cancer Res 1991;51:2403–9.

    PubMed  Google Scholar 

  28. Rognum TO, Lund E, Meling GI, Langmark F. Near diploid large bowel carcinomas have better five-year survival that aneuploid ones. Cancer 1991;6:1077–81.

    Google Scholar 

  29. Kouri M, Pyrhoenen S, Mecklin JP,et al. The prognostic value of DNA ploidy in colorectal carcinoma: a prospective study. Br J Cancer 1990;62:976–81.

    PubMed  Google Scholar 

  30. Rognum TO, Thorud E, Lund E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer 1987;56:633–6.

    PubMed  Google Scholar 

  31. Finan PJ, Quirke P, Dixon JE, Giles GR, Bird CC. Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer? Br J Cancer 1986;54:327–30.

    PubMed  Google Scholar 

  32. Silvestrini R, D'Agnano I, Faranda A,et al. Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. Br J Cancer 1993;67:1042–6.

    PubMed  Google Scholar 

  33. Jass JR, Mukawa K, Goh HS, Love SB, Capellaro D. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J Clin Pathol 1989;42:254–9.

    PubMed  Google Scholar 

  34. Meyer JS, Priolean PG. S phase fractions of colorectal carcinomas related to pathologic and clinical features. Cancer 1981;48:1221–9.

    PubMed  Google Scholar 

  35. Quirke P, Dixon MF, Clayden AD. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 1987;151:275–91.

    Google Scholar 

  36. Scott N, Cross D, Plumb MI, Dixon MF, Quirke P. An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer. Br J Cancer 1992;65:8–10.

    PubMed  Google Scholar 

  37. Wolf RC, D'Emilia JC, Salem RR,et al. Detection of the tumor associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon. J Natl Cancer Inst 1989;81:1913–7.

    PubMed  Google Scholar 

  38. Xu M, Real FX, Welt S, Schussler MH, Oettgen HF, Old LJ. Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer. Int J Cancer 1989;44:985–9.

    PubMed  Google Scholar 

  39. Witzig TE, Loprinzi CL, Gonchoroff NJ,et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 1991;68:879–88.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported in part by the CNR Project ACRO Grant 9202305PF39 and by the AIRC.

About this article

Cite this article

Cavaliere, F., Guadagni, F., D'Agnano, I. et al. Biologic and clinical correlations among ploidy, cell kinetics, and the tumor-associated glycoprotein-72 tissue expression in colorectal cancer. Dis Colon Rectum 37 (Suppl 2), S24–S29 (1994). https://doi.org/10.1007/BF02048427

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02048427

Key words

Navigation